Jason Truman

Jason Truman is a Senior Managing Director in Investment Banking at Leerink Partners focused on Biopharma Mergers & Acquisitions. He brings over 20 years of investment banking experience, where he advised a wide variety of domestic and international biopharma clients in connection with mergers and acquisitions, divestitures, spin-offs/split-offs, takeover defense, proxy contests and capital raising.

Prior to joining the Firm in 2024, Mr. Truman was a Senior Managing Director in the Biopharma Investment Banking Practice at Guggenheim Securities. Prior to that, Mr. Truman specialized in mergers and acquisitions in the biopharma space working at firms including Credit Suisse and Morgan Stanley.

Mr. Truman earned a B.B.A. from the Ross School of Business at the University of Michigan and his MBA from the Darden School of Business at the University of Virginia. He is a member of the Life Science Institute Leadership Council at the University of Michigan.